Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Clinical trial NCT06490159 · RECRUITING

Trial details

NCT number: NCT06490159
Sponsor: City of Hope Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Gastric Cancer Chemotherapy-induced Peripheral Neuropathy Paclitaxel Ramucirumab

Start date: 2018-10-01
Primary completion: 2028-06-18
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.